↓ Skip to main content

Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis

Overview of attention for article published in Pediatric Rheumatology, April 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis
Published in
Pediatric Rheumatology, April 2021
DOI 10.1186/s12969-021-00534-0
Pubmed ID
Authors

Ying Chi, Rong Liu, Zhi-xuan Zhou, Xiao-dong Shi, Yu-chuan Ding, Jian-guo Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 27%
Researcher 2 18%
Student > Ph. D. Student 2 18%
Librarian 1 9%
Professor 1 9%
Other 0 0%
Unknown 2 18%
Readers by discipline Count As %
Nursing and Health Professions 2 18%
Medicine and Dentistry 2 18%
Psychology 1 9%
Agricultural and Biological Sciences 1 9%
Unknown 5 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2021.
All research outputs
#15,019,678
of 23,301,510 outputs
Outputs from Pediatric Rheumatology
#446
of 719 outputs
Outputs of similar age
#242,994
of 431,489 outputs
Outputs of similar age from Pediatric Rheumatology
#14
of 31 outputs
Altmetric has tracked 23,301,510 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,489 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.